Multiple endocrine neoplasia type 1 laboratory findings: Difference between revisions
No edit summary |
No edit summary |
||
Line 18: | Line 18: | ||
==Reference== | ==Reference== | ||
{{Reflist}} | {{Reflist}} | ||
[[Category:Hereditary cancers]] |
Revision as of 14:51, 10 September 2015
Multiple endocrine neoplasia type 1 Microchapters |
Differentiating Multiple endocrine neoplasia type 1 from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Multiple endocrine neoplasia type 1 laboratory findings On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 laboratory findings |
FDA on Multiple endocrine neoplasia type 1 laboratory findings |
CDC on Multiple endocrine neoplasia type 1 laboratory findings |
Multiple endocrine neoplasia type 1 laboratory findings in the news |
Blogs on Multiple endocrine neoplasia type 1 laboratory findings |
Directions to Hospitals Treating Multiple endocrine neoplasia type 1 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 1 laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Laboratory findings consistent with the diagnosis of multiple endocrine neoplasia type 1 include increased parathyroid hormone, increased gastrin, and increased cortisol.
Laboratory Findings
- Laboratory tests may be performed periodically to screen for MEN1 tumors
- Parathyroid hormone
- Prolactin
- Insulin
- Urinary calcium to detect the results of excess hormone production
- Gastrin
- Insulin
- Glucose
- C-peptide
- Proinsulin
- Serum cortisol